There is absolutely no reason why Arrayit (ARYC) should not be trading at $.25 or more per share currently
$24.4 million dollar contract just signed by Arrayit this week and shares are for sale at .0012!!!
Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. - Powerful Science for Life™
ARYC share price has bottomed and a small investment of $5000 could net a return of $100,000 to $500,000. Don't miss opportunity my friends.
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider. Arrayit reports record blood card sales in Q3-16 on microarray immunoassay research apps http://www.arrayit.com/Produc
Arrayit customers in Tel Aviv Israel use Arrayit microarray technology to publish bioprosthetic heart valve advance http:// onlinelibrary.wiley.com/doi/10.1111/xe n.12260/full … Arrayit quotes $160,000 microarray platform to molecular diagnostic leader Akonni Biosystems http://www.akonni.com
Arrayit reports $18,500 microarray platform sale life sciences leader ChemBio Moscow Russia ?http://www.? ?chembio.ru?
Arrayit reports microarray sale to testing leader RDL Reference Laboratory Los Angeles CA http://www.rdlinc.com
Arrayit ships $40,000 microarray platform life sciences leader Daemyung Sciences Seoul Korea http://www.dm4you.com Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
Arrayit customers from Arizona State use Arrayit microarray technology to publish adult stem cell therapy advance http://www. sciencedirect.com/science/articl e/pii/S1873506115000598 …
Can an antibody microarray made with Arrayit technology replace in-situ hybs in HER2 breast cancer diagnostics?... ?http://? ?fb.me/2Xx9b1Oom?
Arrayit reports $30,000 microarray services sale to a top research
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.